FDA OKs Empagliflozin for Children With Type 2 Diabetes

Both Jardiance (empagliflozin) and Synjardy (empagliflozin and metformin) were approved for children aged 10 years and older.
Medscape Medical News

source https://www.medscape.com/viewarticle/993480?src=rss